Approval · Notice of Compliance 13857 · 2012
EPURIS: Notice of Compliance 13857
Issued November 19, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13857
- Date
- November 19, 2012
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Severe nodular inflammatory acne; acne conglobate; recalcitrant acne therapy
Products in this notice
Medicinal ingredients
- ISOTRETINOIN 10 MG per CAP
- ISOTRETINOIN 20 MG per CAP
- ISOTRETINOIN 30 MG per CAP
- ISOTRETINOIN 40 MG per CAP